153 related articles for article (PubMed ID: 37750121)
1. Lymph Node Ratio as a Prognostic Factor for Oral Tongue Squamous Cell Carcinoma: A Retrospective Study.
Sundaram GA; Chokkattu JJ; Krishnan M; Kumar SP; M S; Lakshmanan S
Cureus; 2023 Aug; 15(8):e44109. PubMed ID: 37750121
[TBL] [Abstract][Full Text] [Related]
2. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
3. Can Metastatic Lymph node ratio be used as an independent prognostic factor in Carcinoma tongue?
Bharath VM; Balagopal PG; Nebu AG; Jayasudha AV; Iqbal Ahmed M; Sebastian P
Gulf J Oncolog; 2018 Sep; 1(28):6-10. PubMed ID: 30344127
[TBL] [Abstract][Full Text] [Related]
4. Is Lymph Node Ratio a Prognostic Factor for Patients With Oral Squamous Cell Carcinoma?
Yamagata K; Fukuzawa S; Kanno N; Uchida F; Yanagawa T; Bukawa H
J Oral Maxillofac Surg; 2019 Jul; 77(7):1510-1519. PubMed ID: 30822404
[TBL] [Abstract][Full Text] [Related]
5. Can metastatic lymph node ratio (LNR) predict survival in oral cavity cancer patients?
Sayed SI; Sharma S; Rane P; Vaishampayan S; Talole S; Chaturvedi P; Chaukar D; Deshmukh A; Agarwal JP; D'cruz AK
J Surg Oncol; 2013 Sep; 108(4):256-63. PubMed ID: 23893514
[TBL] [Abstract][Full Text] [Related]
6. Lymph node ratio as a predictor for outcome in oral squamous cell carcinoma: a multicenter population-based cohort study.
Spoerl S; Gerken M; Mamilos A; Fischer R; Wolf S; Nieberle F; Klingelhöffer C; Meier JK; Spoerl S; Ettl T; Reichert TE; Spanier G
Clin Oral Investig; 2021 Apr; 25(4):1705-1713. PubMed ID: 32754787
[TBL] [Abstract][Full Text] [Related]
7. Lymph node ratio as prognostic variable in oral squamous cell carcinomas: Systematic review and meta-analysis.
Huang TH; Li KY; Choi WS
Oral Oncol; 2019 Feb; 89():133-143. PubMed ID: 30732951
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lymph node ratio in survival of non-metastatic breast carcinoma patients.
Singh D; Mandal A
Breast Cancer Res Treat; 2020 Dec; 184(3):839-848. PubMed ID: 32852709
[TBL] [Abstract][Full Text] [Related]
9. High-risk lymph node ratio predicts worse prognosis in patients with locally advanced oral cancer.
Zhao TC; Liang SY; Ju WT; Fu Y; Zhou ZH; Wang LZ; Li J; Zhang CP; Zhang ZY; Zhong LP
J Oral Pathol Med; 2020 Sep; 49(8):787-795. PubMed ID: 32449223
[TBL] [Abstract][Full Text] [Related]
10. Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
Beltramini GA; Belloni LM; Fusco N; Sacconi A; Muti P; Baj A; Bolzoni AR; Giannì AB
Head Neck; 2021 Oct; 43(10):2876-2882. PubMed ID: 34115912
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of lymph node involvement in oral squamous cell carcinoma.
Voss JO; Freund L; Neumann F; Mrosk F; Rubarth K; Kreutzer K; Doll C; Heiland M; Koerdt S
Clin Oral Investig; 2022 Nov; 26(11):6711-6720. PubMed ID: 35895143
[TBL] [Abstract][Full Text] [Related]
12. Impact of lymph node ratio on survival and recurrence outcomes in oral squamous cell carcinoma.
Mamic M; Lucijanic M; Lorencin M; Suton P; Luksic I
Int J Oral Maxillofac Surg; 2022 Oct; 51(10):1257-1263. PubMed ID: 35101318
[TBL] [Abstract][Full Text] [Related]
13. Lymph node ratio is associated with adverse clinicopathological features and is a crucial nodal parameter for oral and oropharyngeal cancer.
Feng Z; Xu QS; Wang C; Li JZ; Mao MH; Li H; Qin LZ; Han Z
Sci Rep; 2017 Jul; 7(1):6708. PubMed ID: 28751709
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of lymph node ratio in patients with squamous cell carcinoma of the floor of the mouth.
Liu XC; Ma SR; Shi S; Zhao YF; Jia J
Int J Oral Maxillofac Surg; 2022 Mar; 51(3):307-313. PubMed ID: 34281747
[TBL] [Abstract][Full Text] [Related]
15. Potential of lymph-node ratio as a prognostic factor for patients with oral squamous cell carcinoma.
Tomo S; Araújo WAF; de Castro TF; Neto SC; Collado FU; Biasoli ÉR; Bernabé DG; Miyahara GI
J Stomatol Oral Maxillofac Surg; 2022 Nov; 123(6):e814-e821. PubMed ID: 35998818
[TBL] [Abstract][Full Text] [Related]
16. Prognostic outcomes of treatment naïve oral tongue squamous cell carcinoma (OTSCC): a comprehensive analysis of 14 years.
Faisal M; Dhanani R; Ullah S; Bakar MA; Irfan N; Malik KI; Loya A; Boban EM; Hussain R; Jamshed A
Eur Arch Otorhinolaryngol; 2021 Aug; 278(8):3045-3053. PubMed ID: 33236214
[TBL] [Abstract][Full Text] [Related]
17. Assessing Prognostic Value of Quantitative Neck Dissection Quality Measures in Patients With Clinically Node-Negative Oral Cavity Squamous Cell Carcinoma.
Farrokhian N; Holcomb AJ; Dimon E; Karadaghy O; Ward C; Whiteford E; Tolan C; Hanly EK; Buchakjian MR; Harding B; Dooley L; Shinn J; Wood CB; Rohde S; Khaja S; Parikh A; Bulbul MG; Penn J; Goodwin S; Bur AM
JAMA Otolaryngol Head Neck Surg; 2022 Oct; 148(10):947-955. PubMed ID: 36074415
[TBL] [Abstract][Full Text] [Related]
18. Lymph node ratio relationship to regional failure and distant metastases in oral cavity cancer.
Hosni A; McMullen C; Huang SH; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; Ringash J; Waldron J; Spreafico A; Weinreb I; de Almeida JR; Brown DH; Irish JC; O'Sullivan B; Goldstein DP; Hope A
Radiother Oncol; 2017 Aug; 124(2):225-231. PubMed ID: 28838425
[TBL] [Abstract][Full Text] [Related]
19. Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
Arun I; Maity N; Hameed S; Jain PV; Manikantan K; Sharan R; Arun P
Head Neck; 2021 Feb; 43(2):520-533. PubMed ID: 33021340
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study.
Polterauer S; Schwameis R; Grimm C; Hillemanns P; Jückstock J; Hilpert F; de Gregorio N; Hasenburg A; Sehouli J; Fürst ST; Strauß HG; Baumann K; Thiel F; Mustea A; Harter P; Wimberger P; Kölbl H; Reinthaller A; Woelber L; Mahner S
Gynecol Oncol; 2019 May; 153(2):286-291. PubMed ID: 30760408
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
